(Q37111770)

18 August 2017

1 reference

title

Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy (English)

1 reference

18 August 2017

3

Adriano Lazzarin

1 reference

18 August 2017

Stefano Benedini

1

1 reference

18 August 2017

Ileana Terruzzi

series ordinal

2

1 reference

18 August 2017

Livio Luzi

series ordinal

4

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

22

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

101-112

1 reference

Exercise, hormones, and body temperature. regulation and action of GH during exercise.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00063030-200822020-00003

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00063030-200822020-00003

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00063030-200822020-00003

Growth hormone-deficient adults are insulin-resistant.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00063030-200822020-00003

10.2165/00063030-200822020-00003

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

18 August 2017

1022167225

0 references

1 reference